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Background: Evidence for the possible effect of vitamin E on head and neck cancers (HNCs) is limited.
Methods:We used individual-level pooled data from 10 case–control studies (5959 cases and 12 248 controls) participating in the
International Head and Neck Cancer Epidemiology (INHANCE) consortium to assess the association between vitamin E
intake from natural sources and cancer of the oral cavity/pharynx and larynx. Adjusted odds ratios (ORs) and 95% confidence
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intervals (CIs) were estimated using unconditional logistic regression models applied to quintile categories of nonalcohol energy-
adjusted vitamin E intake.
Results: Intake of vitamin E was inversely related to oral/pharyngeal cancer (OR for the fifth vs the first quintile category¼ 0.59,
95% CI: 0.49–0.71; P for trend o0.001) and to laryngeal cancer (OR¼ 0.67, 95% CI: 0.54–0.83, P for trend o0.001). There was,
however, appreciable heterogeneity of the estimated effect across studies for oral/pharyngeal cancer. Inverse associations were
generally observed for the anatomical subsites of oral and pharyngeal cancer and within covariate strata for both sites.
Conclusion: Our findings suggest that greater vitamin E intake from foods may lower HNC risk, although we were not able to
explain the heterogeneity observed across studies or rule out certain sources of bias.
Since the mid 1980s, evidence had been accumulating from
laboratory and epidemiological studies on a putative role of anti-
oxidant nutrients, especially b-carotene and vitamin E, in the
prevention of cancer of the oral cavity (Garewal, 1995) and cancers
at other sites, in general (Chen et al, 1988; Block, 1992; Flagg et al,
1995; Schorah, 1995; Byers and Guerrero, 1995). In the absence of
apparent indications of toxicity, these nutrients provided the
possibility to be used widely without close medical supervision and
were then the target for specific chemopreventive intervention
trials, alone or in combination, to take advantage of possible
synergies between them (Shklar and Schwartz, 1993). However, the
results from these experiments were not in line with previous
knowledge and expectations for several reasons (Bardia et al, 2008;
Baumeister et al, 2009; Bjelakovic et al, 2012).
Besides these aspects, traditional single-nutrient analyses and
more recent complementary ones on dietary patterns or total
antioxidant capacity support the hypothesis that protection against
cancer risk may derive from consumption in complex mixtures
with other nutrients and bioactive compounds, as found in the
matrix provided by whole foods or from combinations of
foods (Edefonti et al, 2010a,b; Bravi et al, 2012; La Vecchia et al,
2013). This aspect may be particularly important for vitamin E
intake, as this nutrient derives mainly from vegetables and oils of
different origin, including olive oil.
The International Head and Neck Cancer Epidemiology
(INHANCE) consortium (Hashibe et al, 2007; Conway et al,
2009; http://www.inhance.utah.edu, last accessed 15 March 2015)
was established in 2004 to elucidate the aetiology of head and neck
cancers (HNCs) through pooled analyses of individual-level data
on HNCs on a large scale. Dietary habits have been previously
investigated within the consortium. Among relevant foods and
food groups, an inverse association with HNC risk was found for
higher intakes of selected vegetables and seafood (Chuang et al,
2012). Another analysis focussing on dietary patterns found that a
diet rich in monounsaturated, polyunsaturated and saturated fatty
acids and vitamin E was inversely associated with oral and
pharyngeal cancer and positively associated with laryngeal cancer
(Edefonti et al, 2012). Results on vitamin E supplementation
pointed to a weak and inconsistent inverse association of HNC risk
with ever use and increased duration of use, although the oral
cavity subsite showed a stronger association with supplemental
vitamin E intake. Moreover, the highest frequency category of
consumption of vitamin E supplements was associated with a small
increase in risk of HNC (Li et al, 2012). These inconsistencies in
the results to date demonstrate the need for extra research within
the consortium on the effective contribution of vitamin E intake
from natural sources to HNC risk. Moreover, the INHANCE
consortium offers the unique opportunity to clarify: (1) the
independent role of vitamin E, after the adjustment for other
nutrients previously associated with HNC in independent single-
nutrient analyses within the consortium (Edefonti et al, 2014;
Leoncini et al, 2015); and (2) the combined contribution of
the intakes of vitamin E and these nutrients, using standard
approaches to model the effect of interactions between nutrients on
HNC risk.
The specific goals of this analysis were: (1) to describe and
account for central tendency and variation in the intakes of vitamin
E from natural sources for the populations under examination; (2)
to investigate the association between vitamin E intake and the
risks of two HNC outcomes – oral and pharyngeal cancers
combined and laryngeal cancer – after adjusting for several dietary
and nondietary factors; (3) to explore whether effect estimates
differ by cancer subsites or in subgroups of subjects, with particular
attention to nonsmokers/nondrinkers of alcohol-containing bev-
erages; (4) to explore the potential interaction effect between the
intakes of vitamin E and other selected factors – putatively
associated with HNC and to our main exposure (other selected
nutrients, total fruit and vegetables, supplemental use of vitamin E)
– on the two HNC outcomes of interest.
MATERIALS AND METHODS
Design and participants. Within the version 1.5 of the
INHANCE consortium pooled data set, 10 case–control studies
provided information on vitamin E intake derived from natural
sources at the individual level (Blot et al, 1988; Schantz et al, 1997;
Levi et al, 1998; Bosetti et al, 2003; Peters et al, 2005; Cui et al,
2006; Suzuki et al, 2006; Jayaprakash et al, 2006; Divaris et al, 2010;
Bravi et al, 2013). Details on the individual studies, harmonisation
of questionnaire data and data pooling methods for the consortium
have been previously described (Galeone et al, 2014; Edefonti et al,
2014) and are reported in the Supplementary Table 1. Briefly, three
of the selected studies were from Europe, six were from the United
States and one from Asia. Six were hospital-based and four
were population-based investigations. Study-specific question-
naires included a Food-Frequency Questionnaire (FFQ) section
to assess each subject’s usual diet during a reference period
preceding cancer diagnosis for cases, or interview date for controls
(for details on reproducibility and validity of the study-specific
FFQs, see Edefonti et al, 2014). Overall, number and wording of
FFQ questions were sufficiently detailed to allow for the calculation
of intakes of total energy and several nutrients (U.S. Department of
Health and Human Services, National Center for Health Statistics,
1982; DietSys, 1999; Applied Research Program, National Cancer
Institute, 2005) through study-specific food composition databases
(Dresser, 1983; Salvini et al, 1998; Resource Council, Science and
Technology Agency, the Government of Japan, 2000; Gnagnarella
et al, 2008; U.S. Department of Agriculture, Agricultural Research
Service, 1993, 2013).
Informed consent was obtained from study subjects. The
investigations were approved by the relevant institutional review
boards, according to the rules adopted in each country.
Selection of subjects. Cases were included if their tumour had
been classified by the original study as an invasive tumour of oral
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cavity, oropharynx, hypopharynx, oral cavity or pharynx not
otherwise specified, larynx or HNC unspecified, according to the
International Classification of Diseases for Oncology, 2nd edition
(ICD-O-2) or the International Classification of Diseases, 9th or
10th. Subjects with cancers of the salivary glands (ICD-O-2 codes
C07-C08) or of the nasal cavity/ear/paranasal sinuses (ICD-O-2
codes C30-C31) were excluded. The ICD coding used for the
classification into subsites has been specified in detail previously
(Hashibe et al, 2007).
Subjects with missing information on natural vitamin E intake
(1075 subjects from 6 studies) were removed from the original
data. Subjects having an implausible (o500 or45500 kcal) daily
nonalcohol energy intake (defined as: total energy intake
(kcal) 100 number of drinks per day, as 1 drink per day ¼
100 kcal) (343 subjects) or those having missing values (544
subjects) on nonalcohol energy intake were excluded from the
analysis. Cases with missing information on the site of origin of
their cancer (22 subjects, with 21 belonging to the MSKCC study)
were also removed.
Thus, the present analyses included a total of 18 207 subjects, with
5959 HNC cases and 12 248 controls. There was a total of 1385 oral
cavity cancer cases, 1653 oropharyngeal and 571 hypopharyngeal
cancer cases (2224 pharyngeal cancer cases), 805 unspecified oral
cavity/pharynx cases (giving a total of 4414 oral and pharyngeal
cancer cases combined) and 1545 laryngeal cancer cases.
Definition of the exposure variable. We carried out preliminary
checks on vitamin E definitions, reference periods of intake and
measurement units across studies. In all of the studies, vitamin E
was expressed as a-tocopherol equivalents¼weighted sum of
tochopherols and tochotrienols with vitamin activity. We extracted
information on its intake from natural sources (i.e., no inclusion of
intakes from fortified foods), and we expressed these intakes on a
daily basis.
To assess the comparability of daily intakes across studies, we
inspected the kernel density estimation plot (Scott, 2005) represent-
ing the study-specific empirical distributions of vitamin E intakes.
We also compared study-specific summary statistics of vitamin E
intakes across studies. As preliminary checks revealed differences
across studies, we computed ‘nonalcohol energy-adjusted’ vitamin E
intakes within each study, on both cases and controls, referring to the
residual method (Willett and Stampfer, 1986).
Statistical analysis. Participants from all studies were grouped
into five categories according to quintiles of ‘nonalcohol energy-
adjusted’ vitamin E intakes calculated on the overall sample. We
estimated the odds ratios (ORs) and the corresponding 95%
confidence intervals (CIs) of oral and pharyngeal cancer (including
oral, oropharyngeal, hypopharyngeal and unspecified oral/phar-
yngeal cancer), and laryngeal cancer, separately, for each quintile
category (compared with the lowest reference one) using
unconditional multiple logistic regression models (Hosmer and
Lemeshow, 2000). Tests for linear trend were computed for all
models scoring the quintiles as numbers from 1 to 5. To adjust for
potential confounders, the main analysis included the following set
of variables in all the models: age, sex, education, race/ethnicity,
study centre, cigarette smoking status, cigarette intensity, cigarette
duration, cigar smoking status, pipe smoking status, alcohol
drinking intensity and the interaction between cigarette intensity
and alcohol drinking intensity (see Table 1 for categories used). For
oral and pharyngeal cancer, separate analyses were conducted by
anatomical subsite. For both cancers, stratified analyses were
conducted by age, sex, education, geographic region, body mass
index at time of interview, tobacco smoking, alcohol drinking and
study (see Tables 4 and 5 for categories used, Supplementary
Figure 1), and heterogeneity between strata was tested via
likelihood ratio tests (Hosmer and Lemeshow, 2000).
We further investigated the potential role of other factors
putatively associated with HNC and vitamin E intake on the basis
of the literature, including several nutrients (saturated fats,
monounsaturated fatty acids, polyunsaturated fatty acids, lutein
plus xeaxanthin, total carotenoids, b-carotene equivalents, cryp-
toxanthin, lycopene and vitamin C) (quintile categories of adjusted
nutrient intake via the residual method), total fruits and total
vegetables (categories of intake based on study-specific quartiles
among the controls) and supplement use of vitamin E (never/ever).
For each additional covariate, we proposed a sensitivity analysis,
where the aim is to explore whether the inclusion of the covariate
changes the magnitude of the ORs for vitamin E intake, and an
interaction analysis, where the aim is to assess the magnitude of a
potential interaction between the additional covariate and vitamin E
intake. We therefore fitted models with and without the extra
covariate and the product (interaction) terms for that covariate and
vitamin E categories; we then tested for the effects of those
covariate and interaction effects using likelihood ratio tests. When
the P-value for testing the null hypotheses of no interaction was
40.1, we ignored the interaction and reported results from the
main-effects model. We also conducted an influence analysis in
which each study was excluded one at a time to ensure that the
magnitude of the overall estimates were not dependent on any
specific study (Deeks et al, 2011).
In all the analyses described, when the P-value for heterogeneity
between studies was o0.1, we used a mixed-effects modelling
approach and replaced in the tables the fixed-effects ORs and CIs
with the corresponding mixed-effects ones. We derived those
estimates specifying a random intercept-random slope generalised
linear mixed model (GLMM) with a logit link function and
binomial family (Pinheiro and Bates, 2000).
For both fixed- and mixed-effects models, we adopted a
complete-case approach to the analysis. However, as the Japan
study did not provide information on education level for any
participant (3495 subjects), we defined an extra category of
education including all missing values to avoid the exclusion of
these subjects from the analysis.
All statistical tests were two sided. Calculations were performed
using the open-source statistical computing environment R
(R Core Team, 2014), with its libraries ‘lme4’ (Bates et al, 2011)
and ‘nnet’ (Venables and Ripley, 2002), and Stata (Release 13,
StataCorp LP, College Station, TX, USA).
RESULTS
Selected characteristics of cases and controls are shown in Table 1
for oral and pharyngeal cancer and for laryngeal cancer,
respectively. Over 70% of cases and controls were white. The Italy
Multicenter, US Multicenter and North Carolina studies con-
tributed the largest proportion of cases of both cancer types
combined. The US Multicenter provided cases of oral and
pharyngeal cancer only. Cases were more likely than controls to
smoke tobacco and drink alcohol and to use these products more
frequently and for a greater number of years.
Table 2 gives selected descriptive statistics on raw values of
vitamin E intake across studies and in all the studies combined.
Study-specific distributions were all skewed to the right. The
identified summary statistics showed very different values across
studies. The Italy Multicenter, Switzerland and Milan (2006–2009)
were the top three studies in terms of higher values of vitamin E
intake, whereas the US Multicenter study provided the lowest
values for all the statistics considered.
Table 3 gives separate ORs and the corresponding CIs for oral
and pharyngeal combined and laryngeal cancers by quintile
categories of vitamin E intake. For oral and pharyngeal cancer,
we reported mixed-effects estimates (P-value for heterogeneity
BRITISH JOURNAL OF CANCER Vitamin E and head and neck cancer
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Table 1. Distribution of cases of oral and pharyngeal cancer and laryngeal cancer and controls according to selected variables
(International Head and Neck Cancer Epidemiology (INHANCE) consortium)
Oral and
pharyngeal
cases (%) Controls (%)
Laryngeal
cases (%) Controls (%)
Age (years)
o40 208 4.7 681 5.6 26 1.7 681 5.6
X40 to p44 194 4.4 563 4.6 45 2.9 563 4.6
X45 to p49 446 10.1 949 7.7 123 8.0 949 7.7
X50 to p54 645 14.6 1731 14.1 188 12.2 1731 14.1
X55 to p59 816 18.5 2079 17.0 271 17.5 2079 17.0
X60 to p64 713 16.2 2029 16.6 290 18.8 2029 16.6
X65 to p69 658 14.9 1931 15.8 279 18.1 1931 15.8
X70 to p74 474 10.7 1540 12.6 227 14.7 1540 12.6
X75 260 5.9 743 6.1 96 6.2 743 6.1
Missing 0 0.0 2 0.0 0 0.0 2 0.0
w2 (P-value)a 42.0 (o0.001) 66.5 (o0.001)
Sex
Female 1187 26.9 3541 28.9 244 15.8 3541 28.9
Male 3223 73.0 8702 71.0 1300 84.1 8702 71.0
Missing 4 0.1 5 0.0 1 0.1 5 0.0
w2 (P-value)a 6.3 (0.012) 117.8 (o0.001)
Race
Black 387 8.8 535 4.4 116 7.5 535 4.4
Others (with Asians) 463 10.5 3089 25.2 101 6.5 3089 25.2
White (with Hispanics) 3555 80.5 8596 70.2 1324 85.7 8596 70.2
Missing 9 0.2 28 0.2 4 0.3 28 0.2
w2 (P-value)a 491.5 (o0.001) 281.7 (o0.001)
Study name
Boston 313 7.1 611 5.0 71 4.6 611 5.0
Buffalo 396 9.0 1190 9.7 168 10.9 1190 9.7
Italy Multicenter
Milan 169 3.8 621 5.1 24 1.6 621 5.1
Pordenone 471 10.7 1528 12.5 409 26.5 1528 12.5
Latina 95 2.2 425 3.5 0 0.0 425 3.5
Japan (2001–2005) 407 9.2 3002 24.5 86 5.6 3002 24.5
Los Angeles 246 5.6 828 6.8 60 3.9 828 6.8
Milan (2006–2009) 131 3.0 691 5.6 200 12.9 691 5.6
MSKCC 74 1.7 123 1.0 32 2.1 123 1.0
North Carolina (2002–2006) 687 15.6 1120 9.1 374 24.2 1120 9.1
Switzerland 367 8.3 877 7.2 121 7.8 877 7.2
US Multicenter
Atlanta 129 2.9 134 1.1 0 0.0 134 1.1
New Jersey 467 10.6 459 3.7 0 0.0 459 3.7
Los Angeles 398 9.0 501 4.1 0 0.0 501 4.1
San Francisco 64 1.4 138 1.1 0 0.0 138 1.1
w2 (P-value)a 1121.5 (o0.001) 1092.0 (o0.001)
Education
pJunior high school 863 19.6 2723 22.2 603 39.0 2723 22.2
Some high school 885 20.0 1240 10.1 258 16.7 1240 10.1
High school graduate 588 13.3 1267 10.3 237 15.3 1267 10.3
Technical school, some college 1174 26.6 2305 18.8 214 13.9 2305 18.8
XCollege graduate 491 11.1 1703 13.9 145 9.4 1703 13.9
Missing 413 9.4 3010 24.6 88 5.7 3010 24.6
w2 (P-value)a 766.2 (o0.001) 503.7 (o0.001)
Cigarette smoking status
Never 806 18.3 4868 39.7 90 5.8 4868 39.7
Former 1387 31.4 4330 35.4 707 45.8 4330 35.4
Current 2210 50.1 2986 24.4 735 47.6 2986 24.4
Missing 11 0.2 64 0.5 13 0.8 64 0.5
w2 (P-value)a 1139.6 (o0.001) 755.3 (o0.001)
Cigarette intensity (cigarettes per day)
Never smoker 806 18.3 4868 39.7 91 5.9 4868 39.7
40 to p10 471 10.7 1949 15.9 149 9.6 1949 15.9
410 to p20 1466 33.2 3169 25.9 628 40.6 3169 25.9
420 1633 37.0 2137 17.4 661 42.8 2137 17.4
Missing 38 0.9 125 1.0 16 1.0 125 1.0
w2 (P-value)a 1111.2 (o0.001) 1015.8 (o0.001)
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between studies¼ 0.011), whereas for laryngeal cancer we reported
the fixed-effects ones (P-value for heterogeneity between
studies¼ 0.464). Vitamin E intake was inversely related to oral
and pharyngeal cancer, with an OR of 0.59 (95% CI: 0.49–0.71) for
the fifth quintile compared with the first one (P-value for trend
o0.001). Similarly, the OR for laryngeal cancer was 0.67 (95% CI:
0.54–0.83) for the highest quintile category, with a P-value for
trend o0.001.
Decreasing ORs with higher intakes of vitamin E were observed
across oral and pharyngeal cancer subsites: OR¼ 0.48 (95% CI:
0.34–0.66) for oral cavity, OR¼ 0.63 (95% CI: 0.53–0.75) for
oropharynx and hypopharynx combined and OR¼ 0.57 (95% CI:
0.41–0.78) for oral cavity or pharynx not otherwise specified
(Supplementary Table 2). The ORs for the oropharynx were similar
to those of the hypopharynx site (for instance, for the fifth vs the
first quintile category, OR¼ 0.66, 95% CI: 0.60–0.80 and
OR¼ 0.62, 95% CI: 0.47–0.83, respectively) (data not shown)
but, given the limited number of hypopharyngeal cancer cases, we
decided to combine the results of these subsites.
Table 4 shows the ORs of oral and pharyngeal cancer in strata of
selected variables. No appreciable heterogeneity was detected for
vitamin E intake across strata, with consistent inverse associations
for the third quintile category onwards for all the examined strata.
However, in strata of tobacco consumption, a more marked
protective association was evident for current smokers in the
second and third quintile categories, as compared with non/ex-
smokers (P-value for heterogeneity across strata o0.001). An
appreciable heterogeneity between studies was found for several
strata.
Table 5 shows the ORs of laryngeal cancer in strata of selected
variables. No appreciable heterogeneity was found for vitamin E
intake across strata. An indication of a stronger protective
association was evident in the highest quintile category for subjects
living in Europe, as compared with those living in the United States
or Asia. No appreciable heterogeneity was found between studies
in most of the strata.
In the interaction analyses including one extra nutrient among
the selected ones (saturated fats, monounsaturated fatty acids,
polyunsaturated fatty acids, lutein plus xeaxanthin, total carote-
noids, betacarotene equivalents, cryptoxanthin, lycopene and
vitamin C) or total fruits/total vegetables or supplement use of
vitamin E, no appreciable interaction effect was found between the
additional covariate under examination and natural vitamin E for
either cancer site.
In the sensitivity analyses including one extra nutrient at a time,
likelihood ratio tests pointed to introduce the extra adjustment in
the model for eight out of the nine selected nutrients for oral and
Table 1. ( Continued )
Oral and
pharyngeal
cases (%) Controls (%)
Laryngeal
cases (%) Controls (%)
Duration of cigarette smoking (years)
Never smoker 806 18.3 4868 39.7 91 5.9 4868 39.7
40 to p20 443 10.0 2166 17.7 102 6.6 2166 17.7
420 3132 71.0 5123 41.8 1343 86.9 5123 41.8
Missing 33 0.7 91 0.7 9 0.6 91 0.7
w2 (P-value)a 1116.8 (o0.001) 1133.7 (o0.001)
Cigar smoking
Never cigar user 3583 81.2 8545 69.8 1323 85.6 8545 69.8
Ever smoked X100 cigars in a
lifetime
394 8.9 636 5.2 118 7.6 636 5.2
Missing 437 9.9 3067 25.0 104 6.7 3067 25.0
w2 (P-value)a 33.7 (0.008) 2.8 (0.093)
Pipe smoking
Never pipe user 3579 81.1 8327 68.0 1325 85.8 8327 68.0
Ever smoked X100 pipes in a
lifetime
399 9.0 864 7.1 115 7.4 864 7.1
Missing 436 9.9 3057 25.0 105 6.8 3057 25.0
w2 (P-value)a 1.2 (0.027) 2.8 (0.094)
Alcohol consumption (drinks per day)
Never drinker 548 12.4 3156 25.8 187 12.1 3156 25.8
o1 1030 23.3 4022 32.8 250 16.2 4022 32.8
X1 to 3 973 22.0 2934 24.0 344 22.3 2934 24.0
X3 to 5 647 14.7 1215 9.9 250 16.2 1215 9.9
X5 1216 27.5 921 7.5 514 33.3 921 7.5
w2 (P-value)a 1442.0 (o0.001) 1155.2 (o0.001)
Abbreviation: MSKCC¼Memorial Sloan Kettering Cancer Center.
aMissing values were not considered in the calculation of the w2 test.
Table 2. Descriptive statistics on raw values of vitamin E
intake (mg per day) across studies and in all the studies
combined (International Head and Neck Cancer
Epidemiology (INHANCE) consortium)
Study name 20% Median Mean 80%
Boston 5.37 7.91 9.00 11.58
Buffalo 4.47 6.90 7.78 10.45
Italy Multicenter 10.16 14.08 15.17 19.31
Japan (2001–2005) 6.08 7.42 7.77 9.26
Los Angeles 4.46 6.50 7.51 9.42
Milan (2006–2009) 8.85 11.98 12.76 16.41
MSKCC 5.05 7.22 8.84 11.34
North Carolina (2002–2006) 4.95 7.29 8.04 10.64
Switzerland 9.73 12.90 13.49 16.84
US Multicenter 3.43 4.60 4.88 6.21
All studies combined 5.37 8.30 9.73 13.48
Abbreviation: MSKCC¼Memorial Sloan Kettering Cancer Center.
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Table 3.Odds ratios (ORs)a of oral and pharyngeal combined and laryngeal cancers and corresponding confidence intervals (95%
CIs) on vitamin E intake quintile categories (International Head and Neck Cancer Epidemiology (INHANCE) consortium)
Oral and
pharyngeal cases Controls OR (95% CI)b Pstudies
c
Laryngeal
cases Controls OR (95% CI)b Pstudies
c
I Quintile 976 1479 1 (Reference) 0.011 315 1479 1 (Reference) 0.464
II Quintile 788 1832 0.79 (0.69–0.90) 280 1832 0.94 (0.76–1.16)
III Quintile 704 1944 0.65 (0.56–0.74) 248 1944 0.75 (0.60–0.93)
IV Quintile 707 1922 0.64 (0.55–0.74) 298 1922 0.93 (0.75–1.14)
V Quintile 719 1819 0.59 (0.49–0.71) 261 1819 0.67 (0.54–0.83)
Pfor linear trend o0.001 o0.001
aEstimated from multiple logistic regression models adjusted for age, sex, education, race/ethnicity, study centre, cigarette smoking status, cigarette intensity, cigarette duration, cigar smoking
status, pipe smoking status, alcohol drinking intensity and an interaction term between cigarette intensity and alcohol drinking intensity.
bFor the oral and pharyngeal cancer, heterogeneity between studies was detected (Po0.1) and we reported the mixed-effects estimates derived from the corresponding generalised linear
mixed model; for laryngeal cancer, there was no appreciable heterogeneity between studies and we reported the fixed-effects estimates.
cP for heterogeneity between studies.
Table 4.Odds ratios (ORs)a,b of oral and pharyngeal cancers combined and corresponding confidence intervals (95% CIs) on vitamin E
intake quintile categories in strata of selected covariates (International Head and Neck Cancer Epidemiology (INHANCE) consortium)
II Quintile III Quintile IV Quintile V Quintile
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) Pstudies
c
Age (years)
o55 0.74 (0.59–0.93) 0.61 (0.47–0.78) 0.67 (0.53–0.84) 0.67 (0.50–0.90) 0.006
X55 0.80 (0.68–0.95) 0.66 (0.56–0.78) 0.61 (0.51–0.75) 0.56 (0.43–0.72) 0.004
Pstrata
d 0.739
Sex
Female 0.87 (0.66–1.16) 0.61 (0.46–0.81) 0.61 (0.46–0.81) 0.72 (0.53–0.99) 0.007
Male 0.77 (0.66–0.90) 0.67 (0.57–0.80) 0.67 (0.57–0.79) 0.54 (0.43–0.68) 0.109
Pstrata
d 0.114
Education
pHigh school graduate 0.80 (0.67–0.95) 0.65 (0.52–0.80) 0.66 (0.55–0.79) 0.54 (0.41–0.71) 0.010
XSome college 0.74 (0.60–0.91) 0.65 (0.53–0.80) 0.64 (0.52–0.79) 0.68 (0.55–0.85) 0.170
Pstrata
d 0.587
Geographic regione
Europe 0.78 (0.62–0.99) 0.57 (0.44–0.74) 0.68 (0.46–1.01) 0.51 (0.31–0.83) o0.001
America 0.77 (0.66–0.91) 0.69 (0.58–0.81) 0.63 (0.53–0.74) 0.63 (0.52–0.76) 0.393
Asia 0.66 (0.48–0.92) 0.62 (0.45–0.86) 0.60 (0.43–0.84) 0.47 (0.33–0.65) NE
Pstrata
d 0.322
Body mass index
o25 kgm 2 0.76 (0.63–0.93) 0.59 (0.48–0.73) 0.64 (0.53–0.79) 0.55 (0.44–0.69) 0.321
X25 kgm 2 0.79 (0.65–0.95) 0.72 (0.57–0.89) 0.68 (0.56–0.83) 0.67 (0.53–0.84) 0.030
Pstrata
d 0.434
Tobacco consumption
Never user 1.00 (0.75–1.32) 0.77 (0.57–1.04) 0.65 (0.47–0.88) 0.58 (0.42–0.80) 0.697
Former user 0.96 (0.74–1.23) 0.76 (0.59–0.98) 0.72 (0.55–0.94) 0.68 (0.52–0.89) 0.295
Current user 0.62 (0.50–0.76) 0.52 (0.42–0.64) 0.61 (0.50–0.76) 0.58 (0.47–0.72) 0.115
Pstrata
d o0.001
Alcohol consumptionf
Never/light drinker 0.88 (0.72–1.07) 0.71 (0.58–0.88) 0.79 (0.64–0.96) 0.72 (0.57–0.90) 0.225
Moderate drinker 0.70 (0.54–0.90) 0.63 (0.50–0.79) 0.59 (0.47–0.75) 0.58 (0.42–0.78) 0.008
Heavy drinker 0.71 (0.50–1.01) 0.55 (0.38–0.79) 0.47 (0.32–0.69) 0.43 (0.31–0.59) 0.104
Pstrata
d 0.414
Abbreviation: NE¼ not estimable.
aEstimated from multiple logistic regression models adjusted for age, sex, education, race/ethnicity, study centre, cigarette smoking status, cigarette intensity, cigarette duration, cigar smoking
status, pipe smoking status, alcohol drinking intensity and an interaction term between cigarette intensity and alcohol drinking intensity, when appropriate.
bThe I quintile category was considered as the reference one.
cP for heterogeneity between studies. When the P-value was o0.1 within strata, we reported mixed-effects estimates derived from the corresponding generalised linear mixed model.
dP for heterogeneity across strata. When fixed- and mixed-effects models were estimated for different categories of the same stratification variable, likelihood ratio tests for heterogeneity
across strata had to be based on comparable mixed-effects models and therefore we re-fitted one or more mixed-effects models to replace the original fixed-effects ones. We consistently
reported the corresponding stratum-specific mixed-effects models instead of the fixed-effects ones.
eEurope included Italy Multicenter, Switzerland and Milan (2006–2009) studies. North America included Boston, Buffalo, Los Angeles, Memorial Sloan Kettering Cancer Center (MSKCC), North
Carolina (2002–2006), and US Multicenter studies. Asia included Japan study only. As Asia included Japan study only, there was no possibility to assess heterogeneity between studies in the
Asia stratum.
fThe never/light drinker category included never drinkers and subjects who drinko1 drink per day; the moderate drinker category included subjects drinking between 1 (included) and 5 drinks
per day; the heavy drinker category included subjects drinking X5 drinks per day.
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pharyngeal cancer, and for four of them for laryngeal cancer. In
either case, the point estimates were generally in line with the ones
from the main analysis, although the ORs tended to be higher (data
not shown). Similarly, with the additional adjustment by total fruit
or total vegetable intake, the inverse association between vitamin E
and either cancer site persisted, although the ORs were higher than
before (for oral and pharyngeal cancer: OR¼ 0.70, 95% CI: 0.58–
0.84 for the highest quintile category of vitamin E and adjustment
by total fruit intake, OR¼ 0.67, 95% CI: 0.56–0.80 for the
adjustment by total vegetable intake; for laryngeal cancer:
OR¼ 0.80, 95% CI: 0.68–0.94 for the highest quintile category of
vitamin E and adjustment by total fruit intake, OR¼ 0.76, 95% CI:
0.64–0.90 for the adjustment by total vegetable intake) (data not
shown). With the additional adjustment by supplemental use of
vitamin E intake, the corresponding ORs for natural vitamin E
intake were in line with the ones obtained without such an
adjustment (for oral and pharyngeal cancer: OR¼ 0.62, 95% CI:
0.50–0.77 for the highest quintile category of vitamin E intake; for
laryngeal cancer: OR¼ 0.68, 95% CI: 0.56–0.83, P-values of the
likelihood ratio tests of significance of the interaction effect
o0.001) (data not shown).
Supplementary Figure 1 shows the study-specific ORs of oral
and pharyngeal combined, and laryngeal cancers and correspond-
ing 95% CIs for the highest quintile category of vitamin E
intake as compared with the lowest one. The ORs of oral and
pharyngeal cancers combined were below unity in seven studies
(significant in four) and above unity in two studies (nonsigni-
ficant); the ORs of laryngeal cancer were below unity in five
studies (significant in one) and above unity in three studies
(nonsignificant). Results from the influence analysis were
reassuring, as the exclusion of one study at a time did not
materially change the point estimates.
Table 5. Odds ratios (ORs)a,b of laryngeal cancer and corresponding confidence intervals (95% CIs) on vitamin E intake quintile
categories in strata of selected covariates (International Head and Neck Cancer Epidemiology (INHANCE) consortium)
II Quintile III Quintile IV Quintile V Quintile
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) Pstudies
c
Age (years)
o55 0.98 (0.66–1.47) 0.66 (0.43–1.01) 0.67 (0.44–1.02) 0.52 (0.33–0.80) 0.739
X55 0.94 (0.73–1.22) 0.76 (0.58–0.98) 1.08 (0.84–1.38) 0.77 (0.60–0.99) 0.294
Pstrata
d 0.176
Sex
Female 0.53 (0.32–0.89) 0.33 (0.14–0.76) 0.52 (0.32–0.86) 0.54 (0.27–1.10) 0.677
Male 1.02 (0.82–1.28) 0.80 (0.64–1.01) 0.96 (0.77–1.20) 0.71 (0.50–0.99) 0.015
Pstrata
d 0.114
Education
pHigh school graduate 0.88 (0.68–1.13) 0.70 (0.54–0.91) 0.95 (0.74–1.22) 0.63 (0.49–0.81) 0.371
XSome college 1.08 (0.70–1.65) 0.77 (0.49–1.19) 0.99 (0.65–1.51) 0.96 (0.62–1.49) 0.737
Pstrata
d 0.486
Geographic regione
Europe 0.93 (0.68–1.26) 0.83 (0.61–1.12) 1.08 (0.80–1.44) 0.61 (0.45–0.82) 0.201
America 1.01 (0.74–1.38) 0.71 (0.52–0.99) 0.97 (0.70–1.35) 0.99 (0.71–1.39) 0.830
Asia 1.13 (0.57–2.25) 1.07 (0.55–2.09) 0.84 (0.39–1.82) 0.86 (0.41–1.83) NE
Pstrata
d 0.087
Body mass index
o25 kgm 2 1.10 (0.79–1.53) 0.87 (0.61–1.22) 1.08 (0.76–1.53) 0.71 (0.50–1.02) 0.695
X25 kgm 2 0.89 (0.66–1.19) 0.70 (0.52–0.93) 0.94 (0.71–1.24) 0.72 (0.54–0.96) 0.118
Pstrata
d 0.830
Tobacco consumption
Never user 1.39 (0.63–3.06) 0.89 (0.37–2.13) 0.57 (0.21–1.52) 0.74 (0.30–1.84) 0.793
Former user 1.00 (0.70–1.44) 0.69 (0.47–1.01) 1.07 (0.75–1.52) 0.73 (0.50–1.06) 0.340
Current user 0.82 (0.63–1.08) 0.76 (0.58–0.99) 0.74 (0.56–0.97) 0.68 (0.51–0.90) 0.929
Pstrata
d 0.616
Alcohol consumptionf
Never and light drinker 0.97 (0.68–1.37) 0.65 (0.45–0.95) 1.03 (0.72–1.49) 0.74 (0.50–1.10) 0.223
Moderate drinker 0.92 (0.66–1.29) 0.74 (0.53–1.05) 0.86 (0.61–1.21) 0.78 (0.55–1.11) 0.361
Heavy drinker 1.00 (0.63–1.61) 0.89 (0.56–1.43) 1.17 (0.76–1.82) 0.62 (0.40–0.94) 0.650
Pstrata
d 0.732
Abbreviation: NE¼ not estimable.
aEstimated from multiple logistic regression models adjusted for age, sex, education, race/ethnicity, study centre, cigarette smoking status, cigarette intensity, cigarette duration, cigar smoking
status, pipe smoking status, alcohol drinking intensity and an interaction term between cigarette intensity and alcohol drinking intensity, when appropriate.
bThe I quintile category was considered as the reference one.
cP for heterogeneity between studies. When the P-value was o0.1 within strata, we reported mixed-effects estimates derived from the corresponding generalised linear mixed model.
dP for heterogeneity across strata. When fixed- and mixed-effects models were estimated for different categories of the same stratification variable, likelihood ratio tests for heterogeneity
across strata had to be based on comparable mixed-effects models and therefore we re-fitted one or more mixed-effects models to replace the original fixed-effects ones. We consistently
reported the corresponding stratum-specific mixed-effects models instead of the fixed-effects ones.
eEurope included Italy Multicenter, Switzerland and Milan (2006–2009) studies. North America included Boston, Buffalo, Los Angeles, Memorial Sloan Kettering Cancer Center (MSKCC), North
Carolina (2002–2006), and US Multicenter studies. Asia included Japan study only. As Asia included Japan study only, there was no possibility to assess heterogeneity between studies in the
Asia stratum.
fThe never/light drinker category included never drinkers and subjects who drinko1 drink per day; the moderate drinker category included subjects drinking between 1 (included) and 5 drinks
per day; the heavy drinker category included subjects drinking X5 drinks per day.
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DISCUSSION
The present analysis shows that vitamin E intake was inversely
related to oral and pharyngeal and to laryngeal cancer risk. The
identified associations were generally similar across oral and
pharyngeal cancer subsites and in strata of major confounding and
risk factors. However, some heterogeneity between studies was
detected for oral and pharyngeal cancer.
The term ‘vitamin E’ includes eight different forms of
tocopherols and tocotrienols produced by plants: a-, b-, g- and
d-tocopherol and a-, b-, g- and d-tocotrienol. These fat-soluble
food components are thought to have a primary role in protecting
both low-density lipoproteins and polyunsaturated fatty acids in
cell membranes from oxidation, thus acting indirectly on damage
to DNA and other cellular molecules. Indeed, some of the
photosynthesis-derived reactive oxygen species generated by
oxidation of these compounds in membranes, if not deactivated,
can diffuse into the nucleus and cause mutagenesis (Seidman et al,
1999). Moreover, compounds with vitamin E activity appear to
scavenge oxygen radicals attacking cell membranes and to
terminate free radical chain reactions within cell membranes
(Schorah, 1995).
Tobacco use per se increases oxidative stress, and therefore
enhances the possibility of cancer-causing mutations, oxidisation
of lipids and proteins and alteration of signal transduction
pathways that damage cells. In heavy alcohol drinkers, the entire
nutritional status may be impaired because of malnutrition, and
the deficiencies of vitamins and trace elements may contribute to
alcohol-associated carcinogenesis. Moreover, the increased oxida-
tive stress observed during ethanol metabolism leads to an
increased requirement for glutathion and a-tocopherol (Poschl
and Seitz, 2004; World Cancer Research Fund/American Institute
for Cancer Research, 2007). In the current paper, we found an
interaction between tobacco consumption and vitamin E intake for
oral and pharyngeal cancer, with current smokers experiencing a
stronger risk reduction at the lowest vitamin E intakes as compared
with former and never smokers. No evidence of effect modification
was found for alcohol consumption in either cancer site.
Vitamin E is part of a synergistic biochemical system involving
also vitamin C, the carotenoids, glutathione and selenium that is
designed to protect structural and functional lipids, proteins and
nucleic acids from oxidation (Shklar and Schwartz, 1993). The
synergy between these nutrients as found in whole foods, their
derivation from the same food sources and/or the beneficial effects
of other phytochemical compounds found in fruit and vegetables
may account for the apparent effects of each of these nutrients. In
addition, these reasons may explain why cancer risk is more strongly
associated with total fruit and vegetable consumption than with any
particular nutrient (Pavia et al, 2006; World Cancer Research Fund/
American Institute for Cancer Research, 2007). In our analysis, we
investigated the possibility of an interaction effect between vitamin E
intake and nine potentially related nutrients and that with total fruit
and total vegetable consumption. No interaction was evident for
either oral and pharyngeal cancers combined or laryngeal cancer
and, even when suggested by the likelihood ratio tests, the inclusion
in the models of an adjustment by an extra nutrient or by total fruit/
vegetable consumption did not materially modify the key finding of
an inverse association between higher natural vitamin E intake and
the cancer sites of interest.
Some of the studies included in the present analysis already
contributed to separate original reports on vitamin E intake or
provided data for original publications on data partially over-
lapping with them (McLaughlin et al, 1988; Gridley et al, 1990; Day
et al, 1993; Negri et al, 2000; Bidoli et al, 2003; Suzuki et al, 2006;
Bravi et al, 2013). Besides them, we are aware of at least seven
papers (Riboli et al, 1996; Chainani-Wu, 2002; Lucenteforte et al,
2009) that assess the association between vitamin E intake from
natural sources and HNC and/or its subsites. Among these, one
provided results on oral and pharyngeal cancer (Marshall et al,
1992), two on laryngeal cancer (Freudenheim et al, 1992; Esteve
et al, 1996), two papers concerned UADTC and their subsites (De
Stefani et al, 1999; Wright et al, 2007) and two UADTC overall
(Zheng et al, 1995; Kasum et al, 2002), with the evidence spread
out over the different HNC subsites. Moreover, the same evidence
collected on cancer subsites is generally inconclusive. For oral and
pharyngeal cancer, a case–control study from the Western New
York area showed a weak but nonsignificant protection for higher
vitamin E intakes (Marshall et al, 1992), a case–control study from
Uruguay showed an increased but nonsignificant risk (De Stefani
et al, 1999) and the Alpha-Tocopherol, Beta-Carotene Cancer
Prevention (ATBC) trial showed a nonsignificant inverse associa-
tion in male smokers (Wright et al, 2007). For laryngeal cancer, the
southwestern European study (Esteve et al, 1996) and the ATBC
trial (Wright et al, 2007) reported that vitamin E was related to a
significant reduction in risk, whereas the remaining two studies –
from the United States (Freudenheim et al, 1992) and Uruguay (De
Stefani et al, 1999) – found a weak-to-moderate nonsignificant
reduction in risk. In addition, in the Iowa Women’s Health cohort,
an inverse nonsignificant association was found in the original
study (Zheng et al, 1995) for total vitamin E intake (from both diet
and supplements) and cancers of the mouth/pharynx/esophagus
combined, but no association was observed in its update for dietary
vitamin E intake and UADTC overall (including cancers of the
nasopharynx, larynx and stomach) after 14 years of follow-up
(Kasum et al, 2002).
Concerning vitamin E supplementation, two US case–control
studies in the 1990s provided preliminary evidence for an inverse
association between vitamin E and oral and pharyngeal cancer
(Barone et al, 1992; Gridley et al, 1992). However, more recent
results from a systematic review and meta-analysis (Bardia et al,
2008) and subsequent original studies (Bairati et al, 2005, 2006;
Wright et al, 2007) did not provide support for vitamin E
supplementation on the reduced risk of HNC.
Serum levels of a-tocopherol were related to oral and/or
pharyngeal, and laryngeal cancers in an inconsistent way. The
ATBC trial in Finland and two nested case–control studies
conducted in Finland and the United States provided opposite
inconclusive results for oral and pharyngeal cancer (Knekt et al,
1991; Zheng et al, 1993; Wright et al, 2007). In a case–control study
from India, serum levels of a-tocopherol were 25% lower among
oral cancer cases than among controls (Krishnamurthy and Jaya,
1986). In Finland, increased serum a-tocopherol concentrations
were associated with a lower risk of laryngeal cancer in the
ATBC study (Wright et al, 2007), but similar findings were
nonsignificant in the above-mentioned nested case–control study
(Knekt et al, 1991). A nested case–control study on Japanese–
American men in Hawaii found no difference in the (adjusted)
mean serum levels of a-tocopherol among UADTC cases and
controls (Nomura et al, 1997).
Our analysis has several strengths. The large sample size allowed
to examine the association between vitamin E intake and HNC by
cancer subsite and within relevant subgroups of the study
population with the adequate statistical power. The definition of
the outcome variable was accurate and standardised across studies.
Similarly, we were able to adequately control for the potential
confounding effect of several factors that were harmonised across
studies. For tobacco smoking and alcohol drinking – the main risk
factors for HNC – we accounted for status, intensity and duration
of cigarette smoking, status of cigar and pipe use and intensity of
alcohol drinking. We also proposed a sensitivity analysis where we
assessed the role of several other nutrients, total fruits, total
vegetables and supplemental use of vitamin E in their interaction
with vitamin E.
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However, there are also a few limitations in our work. This
analysis suffers from all the issues inherent to a pooled analysis,
including, among others, if it is reasonable to pool the study-
specific information on the exposure of interest or not, if some
preprocessing/harmonisation of the exposure may help and how to
do it, how to clearly identify the potential sources of heterogeneity
between studies and which statistical approach is more appropriate
for the analysis.
Sources of vitamin E are different across countries. A study
based on the same FFQ administered in the Italy Multicenter,
Milan (2006–2009), and Switzerland studies showed that vitamin E
derived from the following food sources: green salad, spinach/other
greens, tomatoes, vegetable soup, ‘salad with carrots, cucumbers
and peppers’, apples/pears, peaches/apricots/prunes, ‘pasta/rice
with tomato sauce’, ‘tuna/sardines in oil pack’ and ‘chicken/turkey,
roasted, fried, stewed’ (B44.5% cumulative contribution) (Favero
et al, 1997). In the Japanese 102-item FFQ from which our brief
Japanese FFQ was derived, vitamin E was supplied by different
foods and condiments, with well-milled rice, mixed salad oil,
chicken eggs, mixed vegetable oil, spinach, mayonnaise, pumpkin,
safflower oil, margarine and koji miso (soybean paste) being the
top 10 sources (B53% cumulative contribution) (Imaeda et al,
1999). Similarly, major contributors of vitamin E in the US diet
from the second National Health and Nutrition examination
survey (1976–1980) included, among 15 aggregate categories, the
following foods and condiments: fats and oils, vegetables, meat/
poultry/fish, desserts, breakfast cereals, fruit, bread/grain products,
dairy products, mixed main dishes and nuts/seeds (B90%
cumulative contribution), with a major role for highly fortified
foods among single items (Murphy et al, 1990).
As compared with food groups, extra imprecision is likely
present in the measurement of individual nutrients, because of lack
of complete information in the nutrient databases used in their
calculation (Willett, 2013). This may result in stronger and more
consistent associations for food groups than for the corresponding
indexes of nutrient intake.
Stronger associations may be observed for other nutrients than
vitamin E because of the challenge of measuring vitamin E intake
accurately (Byers and Guerrero, 1995). Vitamin E comes largely
from foods enriched with vegetable oils that are more difficult to
accurately define and measure than foods such as citrus fruit, from
which vitamin C is derived (for instance, cumulative contribution
of the top 10 foods contributing mostly to vitamin E: 44.5% vs 82%
for vitamin C, as to the paper based on the Italy Multicenter-Milan
(2006–2009)–Switzerland FFQ (Favero et al, 1997)). Moreover,
vitamin E levels in foods are influenced by processing and
preparation methods.
Results of case–control studies are prone to selection and recall
bias, and nondifferential misclassification of individual intake
might have also occurred because of random measurement error.
In addition, although we adjusted our estimates for major
recognised risk factors for HNC, uncontrolled confounding from
other dietary and nondietary factors cannot be excluded.
Concerning smoking and alcohol consumption, we acknowledge
that the adjustment variables we used are likely to suffer from
mismeasurement to some extent. Oropharyngeal squamous cell
carcinoma has also been linked both epidemiologically and
molecularly to human papillomavirus (Allen et al, 2010). However,
our effect estimates did not materially differ across subsites of oral
and pharyngeal cancer.
Because of the many observations, outcomes and subsets that
are typically made or addressed in epidemiology, multiple
comparisons issue has to be somehow taken into account in
reporting results of epidemiological studies (Berry, 2012). In the
present study, stratified analyses implied carrying out several tests
of significance for oral and pharyngeal cancer and several of them
for laryngeal cancer too. If a 0.1 cutoff was considered for a
heterogeneity deemed to be significant, adjustment for multiple
comparisons is somehow acknowledged, although not formally
taken into account through existing solutions.
In conclusion, the present paper indicates a protective role for
vitamin E in cancers of the oral cavity and pharynx as well as
larynx. Although sources of vitamin E may be different across
countries, this may point to a protective role of foods rich in
vitamin E, including vegetable oils, vegetables and eggs, on cancers
at the mentioned sites.
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